查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1351090

2030 年家庭输液治疗市场预测 -按产品、给药途径、用途、最终用户和地区进行的全球分析

Home Infusion Therapy Market Forecasts to 2030 - Global Analysis By Product, Route of Administration, Application, End Users and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC的数据，2023年全球家庭输液治疗市场规模为368.5亿美元，预计2030年将达到718.1亿美元。

家庭输液治疗涉及患者在家时给药静脉或皮下注射药物给药生物製剂。此外，进行居家输液也需要药物、设备和消耗品。同样，需要护理服务来教导和教育患者和照护者如何在家中安全地给药静脉注射药物。巡诊护理师经常大量参与家庭输液。护理师通常会教导患者和照护者如何自我给药，告知他们可能的副作用和治疗目标，并定期拜访他们检查输液部位并替换敷料。

根据美国临床肿瘤学会 (ASCO) 的说法，居家输液治疗有时会带来风险，需要立即就医。在这些极为罕见的情况下，与不接受生物治疗相关的风险可能超过家庭输液增加的风险。

慢性病增加和高龄化

家庭输液治疗的关键市场促进因素是癌症、糖尿病和心血管疾病等慢性病患病。随着世界人口老化和慢性病的患病增加，长期治疗的需求日益凸显。居家输液疗法是控制这些疾病并提高患者舒适度和生活品质的实用治疗方法。此外，患者和医疗保健专业人员越来越认识到在家中进行复杂治疗的好处，正在推动该市场的成长。

安全问题和法规合规性

家庭输液治疗市场的扩张可能会受到严格的法规要求和安全问题的阻碍。维护病人安全需要确保遵守有关设备、药物处理和感染控制的法律要求。此外，不遵守这些标准而导致的不利事件可能会影响患者对家庭治疗的信任和信心。为了缓解这一限制，至关重要的是实施强有力的安全措施，同时保持患者自主权和政府监督之间的平衡。

实现远端监控和远端医疗现代化

由于远端医疗平台和远端监控技术的整合，家庭输液治疗市场具有巨大的商机。这些创新能够远端即时监测患者生命征象、治疗进展和副作用。此外，远端监控患者的能力可以提高安全性，在发生併发症时能够快速做出反应，为医疗专业人员提供有用的资讯来修改治疗计划，并最终提高患者的安全性，从而改善治疗结果。

资料隐私和安全问题

居家输液治疗越来越依赖科技和数数位平台，引发了资料安全和病患隐私方面的问题。网路安全风险可能会影响敏感患者健康资讯的收集、储存和传输。然而，资料安全问题可能会危及患者的隐私，破坏公众对医疗保健提供者的信任，并引起法律和法规的影响。

COVID-19 的影响：

家庭输液治疗市场受到 COVID-19 大流行的严重影响。虽然医疗保健和供应链的早期低迷暂时减缓了服务提供，但由于担心医院获得性感染，这场大流行最终加速了居家照护的采用。此外，能够进行远端监控和咨询的远端医疗工具也变得至关重要。这场危机凸显了家庭输液疗法作为安全替代品的价值，并引发了技术进步、法规环境的变化和医疗保健协调，最终将再形成市场格局并支持以患者为中心的护理，引发了交付方面的进一步创新。

预计输液帮浦领域在预测期内将是最大的产业。

在预测期内，输液帮浦领域占据最大的收入份额。输液帮浦领域发挥重要作用，让患者在家中准确、受控地服用药物和输液。这些尖端的医疗技术工具可确保精确的给药、监测和​​治疗定制，提高患者安全性、治疗效果和整体便利性。此外，输液帮浦市场同时针对急性和慢性疾病，使医疗保健专业人员能够充满信心地进行治疗，同时使患者能够在康復过程中发挥积极作用。

预计专业製药领域在预测期内年复合成长率最高

预计特种製药领域在预测期内的年复合成长率最高。这种增长是由对必须精确给药、单独给药和持续监测的特殊药物和生物製剂不断增长的需求所推动的。该部门提供的标靶治疗将使患有慢性和复杂疾病的患者受益，包括自体自体免疫疾病、罕见疾病和癌症。此外，药物研究的进步和家庭给药的可能性预计将见证市场扩张的显着增长。

比最大的地区

北美地区占据家庭输液治疗最大的市场。这一优势得益于该地区完善的医疗基础设施、技术进步以及居家照护的日益普及。由于人口高龄化、慢性病盛行率的增加以及对以患者为中心的护理的重视，对家庭输液治疗的需求正在增加，特别是在美国和加拿大。此外，有利的政府法规、支付计划和远距医疗的引入也促进了北美家庭输液服务的发展。

复合年复合成长率最高的地区：

亚太地区是预测期间内年复合成长率最高的家庭输液治疗市场。这种显着的扩张是由于许多变数造成的，包括人们对居家医疗选择的认识提高、慢性病患病上升以及中国、印度和日本等国家医疗基础设施的改善。然而，该地区的人口密度和远端医疗技术的进步推动了家庭输液疗法作为实用且有效的治疗选择的采用。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球家庭输液治疗市场：按产品

  • 点滴帮浦
    • 弹性体
    • 电子机械
    • 重力
  • 滴灌装置
  • 静脉插管
  • 无针头连接器
  • 一次性弹性体泵
  • 胰岛素帮浦
  • 聚氯乙烯泵
  • 便携式电子泵
  • 其他产品

第6章全球家庭输液治疗市场：依给药途径分类

  • 肌肉注射
  • 皮下的
  • 硬脊膜外麻醉
  • 其他给药途径

第7章全球家庭输液治疗市场：依用途

  • 抗感染疾病
  • 内分泌学
    • 糖尿病
  • 供给疗法
    • 运动员
  • 化学处理
  • 经肠营养
  • 肠外营养
  • 特殊药物
  • 正性肌力疗法
  • 疼痛管理
  • 爱滋病毒治疗
  • 移植后治疗
  • 抗生素的给药
  • 血友病的治疗
  • 其他用途

第8章全球家庭输液治疗市场：依最终用户分类

  • 病人
  • 护士
  • 医院
  • 家庭护理设置
  • 护理中心
  • 其他最终用户

第9章全球家庭输液治疗市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • Option Care Health Inc.
  • Nipro Corporation
  • Baxter International, Inc.
  • JMS Co., Ltd.
  • Micrel Medical Devices SA
  • PharMerica
  • B. Braun Melsungen AG
  • Terumo Corporation
  • CVS/Coram
  • Dickinson and Company
  • Eitan Medical Ltd
  • McKesson Medical-Surgical Inc.
  • Smiths Medical.
  • Caesarea Medical Electronics
  • BriovaRx/Diplomat（UnitedHealth Optum）
  • ICU Medical, Inc.
  • CareFusion Corporation
  • McLaren Health Care
  • Becton Dickinson and Company
  • CU Medical, Inc.
Product Code: SMRC23777

According to Stratistics MRC, the Global Home Infusion Therapy Market is accounted for $36.85 billion in 2023 and is expected to reach $71.81 billion by 2030 growing at a CAGR of 10% during the forecast period. Home infusion therapy involves giving a patient intravenously or subcutaneously administered medications or biological while they are at home. Moreover, the drug, equipment, and supplies are required to perform a home infusion. Similarly, nursing services are required to instruct and educate the patient and caregivers on how to safely administer infusion drugs at home. Home infusion frequently involves a significant contribution from visiting nurses. Typically, nurses teach patients or caregivers how to self-administer medications, inform them of potential side effects and therapy objectives, and make regular visits to check on the infusion site and change dressings.

According to the American Society of Clinical Oncology (ASCO), home infusion therapy may occasionally provide dangers that necessitate rapid medical attention. In these incredibly rare circumstances, the dangers connected with not having access to biological therapy may exceed the elevated risk of a home infusion.

Market Dynamics:

Driver:

Increasing chronic conditions and an aging population

A significant market driver for home infusion therapy is the rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases. A need for long-term treatments arises as the world population ages and the prevalence of chronic diseases increases. A practical treatment for controlling these conditions that also improves the comfort and quality of life of the patient is home infusion therapy. Additionally, the benefits of administering complex treatments at home are understood by both patients and healthcare professionals, which have caused this market to grow.

Restraint:

Safety issues and regulatory compliance

Home infusion therapy market expansion may be hampered by strict regulatory requirements and safety concerns. Maintaining patient safety requires ensuring compliance with legal requirements for tools, medication handling, and infection control. Furthermore, adverse events that result from not adhering to these standards can affect patient confidence and trust in home-based treatments. To lessen this restriction, it is crucial to implement strong safety measures while maintaining a balance between patient autonomy and governmental oversight.

Opportunity:

Modernization of remote monitoring and telehealth

The market for home infusion therapy has a sizable opportunity due to the integration of telehealth platforms and remote monitoring technology. These innovations allow for remote, real-time monitoring of patient vital signs, treatment development, and adverse reactions. Moreover, the ability to monitor patients remotely improves safety, allows for quick response in the event of complications, and gives medical professionals useful information to modify treatment plans, ultimately leading to better patient outcomes.

Threat:

Data privacy and security issues

Home infusion therapy is becoming more and more dependent on technology and digital platforms, which raises questions about data security and patient privacy. Cybersecurity risks can affect the gathering, storing, and transmission of sensitive patient health information. However, data security issues can jeopardize patient confidentiality, erode public confidence in healthcare providers, and result in legal and regulatory repercussions.

COVID-19 Impact:

The market for home infusion therapy was significantly impacted by the COVID-19 pandemic. Although the initial hiccups in healthcare and supply chains temporarily slowed down service delivery, the pandemic ultimately accelerated the adoption of home-based care due to concerns about hospital-acquired infections. Moreover, telehealth tools have become essential for enabling remote monitoring and consultations. The crisis highlighted the value of home infusion therapy as a secure substitute, triggering technological advancements, regulatory changes, and healthcare collaborations that ultimately reshaped the market's landscape and sparked additional innovation in patient-centered care delivery.

The infusion pumps segment is expected to be the largest during the forecast period

During the forecasted period, the infusion pumps segment was responsible for the largest revenue share. By providing patients with precise and controlled medication and fluid administration in their own homes, the infusion pump segment plays a crucial role. These cutting-edge medical technology tools guarantee precise dosing, monitoring, and therapy customization, improving patient safety, treatment effectiveness, and general convenience. Moreover, the infusion pump market targets both acute and chronic medical conditions, allowing healthcare professionals to confidently administer therapies while empowering patients to take an active role in their recovery processes.

The specialty pharmaceuticals segment is expected to have the highest CAGR during the forecast period

The segment for specialty pharmaceuticals will have the highest CAGR during the forecast period. This growth can be attributed to the rise in demand for specialty drugs and biologics that need to be administered with accuracy, given to each patient individually, and continuously monitored. The targeted therapies provided by this segment benefit patients with chronic and complex conditions, such as autoimmune disorders, rare diseases, and cancer. Furthermore, due to advances in pharmaceutical research and the potential for home-based administration, there is a huge growth for the market expansion.

Region with largest share:

The North American region holds the largest market share for home infusion therapy. The region's established healthcare infrastructure, technological advancements, and rising popularity of home-based care options can all be credited with this dominance. Particularly in the United States and Canada, the demand for home infusion therapy has increased as a result of the aging population, the increasing prevalence of chronic diseases, and the focus on patient-centered care. Additionally, the development of home infusion services in North America has also been aided by favourable governmental regulations, payment schemes, and the incorporation of telehealth.

Region with highest CAGR:

The Asia-Pacific region has the market for home infusion therapy with the highest CAGR during the forecast period. This remarkable expansion is attributed to a number of variables, including the rising awareness of home-based healthcare options, the rise in chronic disease prevalence, and the development of the healthcare infrastructure in nations like China, India, and Japan. However, the adoption of home infusion therapy as a practical and efficient treatment option is being fueled by the area's dense population and advancements in telehealth technology.

Key players in the market:

Some of the key players in Home Infusion Therapy market include: Option Care Health Inc., Nipro Corporation, Baxter International, Inc., JMS Co., Ltd., Micrel Medical Devices SA, PharMerica, B. Braun Melsungen AG, Terumo Corporation, CVS/Coram , Dickinson and Company, Eitan Medical Ltd , McKesson Medical-Surgical Inc., Smiths Medical. , Caesarea Medical Electronics, BriovaRx/Diplomat (UnitedHealth Optum) , ICU Medical, Inc., CareFusion Corporation, McLaren Health Care, Becton Dickinson and Company and CU Medical, Inc.

Key Developments:

In June 2023, Baxter International, an American healthcare company, introduced Progressa+ Next Gen ICU bed for addressing critical needs of patients at their homes. This technology makes it easier for nurses to take care of patients, while supporting therapy at home.

In May 2023, Option Care Health, a healthcare service provider, created an independent platform for home care services in collaboration with Amedisys Inc., a leading provider of home health services. This platform comprises pharmacists, dieticians, therapists, social workers, and others for providing high quality healthcare services at home.

In April 2023, CareFusion, currently owned by Becton Dickinson, an American medical technology company, launched an advanced ultrasound technology to provide clinicians with optimal IV insertions. More than 90% hospitalized patients receive the IV therapy, thus contributing towards the market growth of home infusion therapy.

Products Covered:

  • Infusion Pumps
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors
  • Disposable Elastomeric Pumps
  • Insulin Pumps
  • PCA Pumps
  • Electronic Ambulatory Pumps
  • Other Products

Routes of Administration Covered:

  • Intramuscular
  • Subcutaneously
  • Epidural
  • Other Routes of Administration

Applications Covered:

  • Anti-Infective
  • Endocrinology
  • Hydration Therapy
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Inotropic Therapy
  • Pain Management
  • HIV Therapies
  • Post-transplant Therapies
  • Antibiotic Administration
  • Haemophilia Therapies
  • Other Applications

End Users Covered:

  • Patients
  • Nurse
  • Hospitals
  • Home Care Settings
  • Long-Term Care Center
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Home Infusion Therapy Market, By Product

  • 5.1 Introduction
  • 5.2 Infusion Pumps
    • 5.2.1 Elastomeric
    • 5.2.2 Electromechanical
    • 5.2.3 Gravity
  • 5.3 Intravenous Sets
  • 5.4 IV Cannulas
  • 5.5 Needleless Connectors
  • 5.6 Disposable Elastomeric Pumps
  • 5.7 Insulin Pumps
  • 5.8 PCA Pumps
  • 5.9 Electronic Ambulatory Pumps
  • 5.10 Other Products

6 Global Home Infusion Therapy Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Intramuscular
  • 6.3 Subcutaneously
  • 6.4 Epidural
  • 6.5 Other Routes of Administration

7 Global Home Infusion Therapy Market, By Application

  • 7.1 Introduction
  • 7.2 Anti-Infective
  • 7.3 Endocrinology
    • 7.3.1 Diabetes
  • 7.4 Hydration Therapy
    • 7.4.1 Athletes
  • 7.5 Chemotherapy
  • 7.6 Enteral Nutrition
  • 7.7 Parenteral Nutrition
  • 7.8 Specialty Pharmaceuticals
  • 7.9 Inotropic Therapy
  • 7.10 Pain Management
  • 7.11 HIV Therapies
  • 7.12 Post-transplant Therapies
  • 7.13 Antibiotic Administration
  • 7.14 Haemophilia Therapies
  • 7.15 Other Applications

8 Global Home Infusion Therapy Market, By End User

  • 8.1 Introduction
  • 8.2 Patients
  • 8.3 Nurse
  • 8.4 Hospitals
  • 8.5 Home Care Settings
  • 8.6 Long-Term Care Center
  • 8.7 Other End Users

9 Global Home Infusion Therapy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Option Care Health Inc.
  • 11.2 Nipro Corporation
  • 11.3 Baxter International, Inc.
  • 11.4 JMS Co., Ltd.
  • 11.5 Micrel Medical Devices SA
  • 11.6 PharMerica
  • 11.7 B. Braun Melsungen AG
  • 11.8 Terumo Corporation
  • 11.9 CVS/Coram
  • 11.10 Dickinson and Company
  • 11.11 Eitan Medical Ltd
  • 11.12 McKesson Medical-Surgical Inc.
  • 11.13 Smiths Medical.
  • 11.14 Caesarea Medical Electronics
  • 11.15 BriovaRx/Diplomat (UnitedHealth Optum)
  • 11.16 ICU Medical, Inc.
  • 11.17 CareFusion Corporation
  • 11.18 McLaren Health Care
  • 11.19 Becton Dickinson and Company
  • 11.20 CU Medical, Inc.

List of Tables

  • Table 1 Global Home Infusion Therapy Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Home Infusion Therapy Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Home Infusion Therapy Market Outlook, By Infusion Pumps (2021-2030) ($MN)
  • Table 4 Global Home Infusion Therapy Market Outlook, By Elastomeric (2021-2030) ($MN)
  • Table 5 Global Home Infusion Therapy Market Outlook, By Electromechanical (2021-2030) ($MN)
  • Table 6 Global Home Infusion Therapy Market Outlook, By Gravity (2021-2030) ($MN)
  • Table 7 Global Home Infusion Therapy Market Outlook, By Intravenous Sets (2021-2030) ($MN)
  • Table 8 Global Home Infusion Therapy Market Outlook, By IV Cannulas (2021-2030) ($MN)
  • Table 9 Global Home Infusion Therapy Market Outlook, By Needleless Connectors (2021-2030) ($MN)
  • Table 10 Global Home Infusion Therapy Market Outlook, By Disposable Elastomeric Pumps (2021-2030) ($MN)
  • Table 11 Global Home Infusion Therapy Market Outlook, By Insulin Pumps (2021-2030) ($MN)
  • Table 12 Global Home Infusion Therapy Market Outlook, By PCA Pumps (2021-2030) ($MN)
  • Table 13 Global Home Infusion Therapy Market Outlook, By Electronic Ambulatory Pumps (2021-2030) ($MN)
  • Table 14 Global Home Infusion Therapy Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 15 Global Home Infusion Therapy Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 16 Global Home Infusion Therapy Market Outlook, By Intramuscular (2021-2030) ($MN)
  • Table 17 Global Home Infusion Therapy Market Outlook, By Subcutaneously (2021-2030) ($MN)
  • Table 18 Global Home Infusion Therapy Market Outlook, By Epidural (2021-2030) ($MN)
  • Table 19 Global Home Infusion Therapy Market Outlook, By Other Routes of Administration (2021-2030) ($MN)
  • Table 20 Global Home Infusion Therapy Market Outlook, By Application (2021-2030) ($MN)
  • Table 21 Global Home Infusion Therapy Market Outlook, By Anti-Infective (2021-2030) ($MN)
  • Table 22 Global Home Infusion Therapy Market Outlook, By Endocrinology (2021-2030) ($MN)
  • Table 23 Global Home Infusion Therapy Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 24 Global Home Infusion Therapy Market Outlook, By Hydration Therapy (2021-2030) ($MN)
  • Table 25 Global Home Infusion Therapy Market Outlook, By Athletes (2021-2030) ($MN)
  • Table 26 Global Home Infusion Therapy Market Outlook, By Chemotherapy (2021-2030) ($MN)
  • Table 27 Global Home Infusion Therapy Market Outlook, By Enteral Nutrition (2021-2030) ($MN)
  • Table 28 Global Home Infusion Therapy Market Outlook, By Parenteral Nutrition (2021-2030) ($MN)
  • Table 29 Global Home Infusion Therapy Market Outlook, By Specialty Pharmaceuticals (2021-2030) ($MN)
  • Table 30 Global Home Infusion Therapy Market Outlook, By Inotropic Therapy (2021-2030) ($MN)
  • Table 31 Global Home Infusion Therapy Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 32 Global Home Infusion Therapy Market Outlook, By HIV Therapies (2021-2030) ($MN)
  • Table 33 Global Home Infusion Therapy Market Outlook, By Post-transplant Therapies (2021-2030) ($MN)
  • Table 34 Global Home Infusion Therapy Market Outlook, By Antibiotic Administration (2021-2030) ($MN)
  • Table 35 Global Home Infusion Therapy Market Outlook, By Haemophilia Therapies (2021-2030) ($MN)
  • Table 36 Global Home Infusion Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 37 Global Home Infusion Therapy Market Outlook, By End User (2021-2030) ($MN)
  • Table 38 Global Home Infusion Therapy Market Outlook, By Patients (2021-2030) ($MN)
  • Table 39 Global Home Infusion Therapy Market Outlook, By Nurse (2021-2030) ($MN)
  • Table 40 Global Home Infusion Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 41 Global Home Infusion Therapy Market Outlook, By Home Care Settings (2021-2030) ($MN)
  • Table 42 Global Home Infusion Therapy Market Outlook, By Long-Term Care Center (2021-2030) ($MN)
  • Table 43 Global Home Infusion Therapy Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.